Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-06-07
2000-08-22
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546126, A61K 3144, C07D40100
Patent
active
061073075
ABSTRACT:
This invention provides 3-(bicyclic heteroaryl)-8-azabicyclo[3.2.1]oct-2-enes and 3-(bicyclic heteroaryl)-8-azabicyclo[3.2.1]octanes which are useful for the inhibition of serotonin reuptake in mammals.
REFERENCES:
patent: 2902490 (1959-09-01), Archer et al.
patent: 4959367 (1990-09-01), King et al.
patent: 5234931 (1993-08-01), Glamkowski et al.
patent: 5491148 (1996-02-01), Berger et al.
Layer, et. al., Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors, European Journal of Pharmacology, 309, pp. 159-165, 1996.
Langlois, et. al., Synthesis of quinazoline-2,4-dione and naphthalimide derivatives as new 5-HT3 receptor antagonists, J. Med. Chem. 29, pp. 925-940, 1994.
Clark, et. al., "2-(Quinuclinin-3-yl)pyrido[4,3-b]indol-1-ones and Isoquinolin-1-ones. Potent Conformationally Restricted 5-HT3 Receptor Antagonists", Journal of Medicinal Chemistry, vol. 36, pp. 2645-2657, 1993.
Repke, et. al., Abbreviated Ibogaine Congeners. Synthesis and Reachtions of Tropan-3-yl-2- and -3-indoles. "Investigation of an Unusual Isomerization of 2-Substituted Indoles Using Computational and Spectroscopic Techniques", J. of Org. Chem., vol. 59, 1994.
King, et. al., Benzotriazinones as "Virtual Ring" Mimics of o-Methoxybenzamides: Novel and Potent 5-HT3 Receptor Antagonists, Journal of Medicinal Chemistry, vol. 33, No. 11, pp. 2942-2944.
Journal of Chemistry, 1975, 40, 2525-2529.
J. Med. Chem, 1995, 38, 379-388.
J. Med Chem, 1996, 39, 4027-2035.
Audia James Edmund
McDaniel Stacey Leigh
Nissen Jeffrey Scott
Davis Zinna Northington
Eli Lilly and Company
Robinson Binta
Titus Robert D.
LandOfFree
Inhibition of serotonin reuptake does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of serotonin reuptake, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of serotonin reuptake will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581423